ATI RN
ATI Pharmacology Assessment 1 Questions
Extract:
Question 1 of 5
A nurse is caring for a client receiving an intermittent IV bolus of gentamicin twice daily. Which of the following laboratory values should the nurse monitor while the client is receiving this medication? (Select all that apply.)
Correct Answer: C,E
Rationale: Serum creatinine should be monitored because gentamicin can cause nephrotoxicity. WBC count should be monitored because gentamicin can cause leukopenia or other changes in white blood cell counts.
Question 2 of 5
A nurse is providing teaching to a client who has osteoporosis and is starting to take oral ibandronate. Which of the following instructions should the nurse include in the teaching?
Correct Answer: D
Rationale: Taking one tablet of ibandronate on the same date each month is correct. This ensures consistent dosing and helps maintain the medication's effectiveness.
Question 3 of 5
A nurse is preparing to administer medications to a client who has type 1 diabetes mellitus. The client takes lispro insulin and has a new prescription for pramlintide. Which of the following actions should the nurse take?
Correct Answer: B
Rationale: Monitoring for hypoglycemia for 3 hours after pramlintide administration is crucial. Pramlintide can increase the risk of insulin-induced hypoglycemia.
Question 4 of 5
A nurse is talking with a client who has a new prescription for an ipratropium inhaler to treat exercise-induced bronchospasm. Which of the following client statements should the nurse report to the provider?
Correct Answer: C
Rationale: An allergy to atropine is significant because ipratropium is chemically related to atropine, which could lead to a severe allergic reaction.
Question 5 of 5
A nurse is assessing a client who is taking beclomethasone. Which of the following findings is the priority to report to the provider?
Correct Answer: A
Rationale: A white coating in the mouth can indicate oral thrush, a common side effect of inhaled corticosteroids like beclomethasone, requiring prompt treatment.